Minimally Invasive Hysterectomy May Be Underused

This article originally appeared here.
Share this content:
Minimally Invasive Hysterectomy May Be Underused
Minimally Invasive Hysterectomy May Be Underused

MONDAY, Oct. 12, 2015 (HealthDay News) -- In 2012, minimally invasive hysterectomy was underused for gynecologic cancers, according to a study published online Oct. 7 in Obstetrics & Gynecology.

Katharine M. Esselen, M.D., M.B.A., from Brigham and Women's Hospital in Boston, and colleagues conducted a cross-sectional analysis of the 2012 National Inpatient Sample to examine hysterectomies in the United States performed for gynecologic malignancies.

The researchers found that an estimated 46,450 hysterectomies were performed for gynecologic malignancy in 2012 in the United States. Of these, 61, 9, 27, and 3 percent, respectively, were performed for uterine, cervical, ovarian, and other gynecologic malignancies. Minimally invasive hysterectomy was used in 50, 43, and 8.5 percent of uterine, cervical, and ovarian cancer cases, respectively. For black women, the odds of undergoing minimally invasive hysterectomy were decreased for uterine and cervical cancers (adjusted odds ratios, 0.5 and 0.56). For uterine cancer, the odds of undergoing minimally invasive hysterectomy were decreased for those without insurance or with Medicaid. Patients in the South and West versus the Northeast were less and more likely, respectively, to undergo minimally invasive hysterectomy for uterine cancer (adjusted odds ratios, 0.72 and 1.48, respectively).

"Minimally invasive hysterectomy for gynecologic malignancies remained underused in 2012; there were striking racial disparities associated with use of minimally invasive hysterectomy for uterine and cervical cancers," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »